TransCode Therapeutics, Inc. (RNAZ) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -4.98B | -8.14M | -4.08M | -4.19M | -3.1M | -3.15M | -3.91M | -2.34M | -3.94M | -5.66M | -3.51M | -4.39M | -4.51M | -4.02M | -4.42M | -3.37M | -3.95M | -1.6M | -3.84M | -161.66K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -160638.36% | -158.78% | -4.36% | -79.26% | 21.34% | 44.45% | -11.6% | 46.72% | 12.77% | -40.89% | 20.72% | -30.23% | -14.31% | -151.11% | -15.06% | -1985.94% | -656.21% | -526.54% | -2837.46% | - |
| Net Income | -17.79B | -1.37B | -4.86M | -4.28M | -12.09M | -5.92M | -2.32M | -5.19M | -3.33M | -4.09M | -5.3M | -4.34M | -4.82M | -5.13M | -4.29M | -4.67M | -3.47M | -2.8M | -2.33M | 2.77M |
| Depreciation & Amortization | 23.94M | -6.34M | 4.78K | 13.44K | 51.17K | 122.86K | 127.52K | 142.83K | 141.65K | 140.17K | 138.78K | 137.59K | 100.2K | 29.5K | 24.8K | 22.7K | 21.6K | 28.99K | 7.54K | 4.69K |
| Stock-Based Compensation | 0 | -95.71M | 0 | 0 | 157.73K | 168.77K | 204.48K | 1.14M | 183.15K | 0 | 392.33K | 175.48K | 158.76K | 130.56K | 105.6K | 98.6K | 60.57K | 39K | 0 | 0 |
| Deferred Taxes | 231.31M | 226.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.15M | -2.06M | 0 | 0 | 0 | -265.92K | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 12.55B | 1.24B | 413.48K | 293.22K | 9.23M | 1.54M | 0 | 0 | 0 | 310.31K | -1.15M | 2.06M | 0 | 0 | 0 | 265.92K | 0 | 38.77K | -709.56K | -3.14M |
| Working Capital Changes | 2.12M | 340.58K | 354.61K | -224.5K | -455K | 942.35K | -1.92M | 1.56M | -935.21K | -2.03M | 1.26M | -363.12K | 44.42K | 954.27K | -262.82K | 1.18M | -560.67K | 1.09M | -811.53K | 205.73K |
| Change in Receivables | 952.46K | -754.16K | -22.17K | 146.31K | -322K | 11.95K | -11.95K | 0 | 0 | 0 | 0 | 0 | 360.23K | 127.65K | -453.15K | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.77M | -43.15K | 1.4M | -944.69K | 0 | 0 | -1.14M | 0 | 0 | -2.09M | 1.96M | -1.74M | 575.98K | 609.45K | 2.03M | -121.93K | -677.93K | 518.91K | 1.5M | -86.68K |
| Cash from Investing | 0 | -4.44K | 0 | 0 | 0 | -500 | -12.87K | -4.55K | -3.84K | 0 | -4.61K | -18.11K | -12.9K | -28.21K | 0 | -42.05K | -30.66K | -82.73K | -71.55K | -22.24K |
| Capital Expenditures | 0 | -6.66K | 0 | 0 | 0 | -500 | -12.87K | -4.55K | -3.84K | 0 | -4.61K | -18.11K | -12.9K | -28.21K | 0 | -42.05K | -30.66K | -85.73K | -71.55K | -22.24K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 2.22K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 0 | 0 |
| Cash from Financing | 0 | 23.12M | -455.73K | 0 | 8.86M | 7.08M | 2.45M | 785.2K | 6.09M | 978.15K | 7.39M | 6.36M | 1.18M | 225.82K | -225.82K | 5.98K | 5.99K | 9.48K | 26.34M | 164.51K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 8.86M | 7.08M | 2.45M | 785.2K | 6.09M | 978.15K | 7.26M | 6.5M | 1.18M | 0 | 0 | 0 | 5.99K | 0 | 26.36M | 3.64K |
| Dividends Paid | -1.73B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 1.73B | 23.12M | -455.73K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 135.8K | -135.8K | 0 | 225.82K | -225.82K | 5.98K | 0 | 9.48K | -29.27K | 160.87K |
| Net Change in Cash | -4.98B | 14.98M | -4.54M | -4.19M | 5.76M | 3.94M | -1.48M | -1.56M | 2.15M | -4.69M | 3.88M | 1.95M | -3.35M | -3.82M | -4.65M | -3.41M | -3.97M | -1.67M | 22.42M | -19.39K |
| Free Cash Flow | -4.98B | -8.15M | -4.08M | -4.19M | -3.1M | -3.15M | -3.93M | -2.34M | -3.94M | -5.66M | -3.51M | -4.41M | -4.53M | -4.05M | -4.42M | -3.41M | -3.98M | -1.69M | -3.91M | -183.9K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -160638.36% | -158.95% | -4.02% | -78.91% | 21.42% | 44.44% | -11.82% | 46.84% | 12.93% | -39.91% | 20.62% | -29.16% | -13.75% | -140.02% | -12.96% | -1756.57% | -566.03% | -560.09% | -2892.15% | - |
| FCF per Share | -5428.83 | -8.89 | -4.90 | -5.03 | -17.98 | -8.84 | -11.02 | -10.97 | -25.29 | -1054.62 | -32.08 | -144.61 | -243.45 | -8317.80 | -272.61 | -210.48 | -245.31 | -3485.18 | -271.71 | -12.29 |
| FCF Conversion (FCF/Net Income) | 279.90x | 0.61x | 0.84x | 0.98x | 0.26x | 0.53x | 1.69x | 0.45x | 1.18x | 1.39x | 0.66x | 1.01x | 0.94x | 0.78x | 1.03x | 0.72x | 1.14x | 0.57x | 1.65x | -0.06x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 9.55K | 1.43K | 5.65K | 0 | 11.31K | 926 | 8.3K | 16.49K | 15.49K | 704 | 0 | 17.87K | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |